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mAbstract
Background: The purpose of this research is to study the relationship between
superoxide dismutase (SOD) and lung redox state in an animal model of sepsis.
Methods: Sepsis was induced in rats by the cecal ligation and perforation model
(CLP). After 3, 6, and 12 h, CLP protein content and expression of SOD1, SOD2, and
SOD3 were evaluated, and SOD activity was assessed. Oxidative damage was determined
by quantifying nitrotyrosine content. Lung localization of SOD3 was performed by
immunohistochemistry. The protective effect of a SOD mimetic on oxidative damage,
inflammation, and lung permeability was assessed 12 and 24 h after sepsis induction.
Results: Lung levels of SOD1 decreased 3 and 12 h after sepsis, but SOD2 and SOD3
increased, as well as SOD activity. These alterations were not associated with changes
in sod gene expression. Nitrotyrosine levels increased 3 and 12 h after sepsis. The
administration of a SOD mimetic decreased nitrotyrosine and proinflammatory cytokine
levels and improved lung permeability.
Conclusions: SOD2 and SOD3 increased after sepsis induction, but this was insufficient
to protect the lung. Treatments based on SOD mimetics could have a role in lung injury
associated with sepsis.
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Several molecular mechanisms of inflammation and cellular damage have been impli-
cated in the pathogenesis of sepsis including excessive reactive oxygen species (ROS)
generation [1]. Main sources of ROS in the lung during sepsis are inflammatory cells
and mitochondria [2,3]. Production of ROS leads to lipid, protein, and extracellular
matrix damage, which increases pulmonary inflammation [4,5].
Antioxidants are known to counteract the deleterious effects of ROS. Superoxide dis-
mutase (SOD) is a component of antioxidant response and catalyzes the conversion of
superoxide anions to hydrogen peroxide [6]. Three SODs are found in mammals and
regulate the concentration of superoxide: a cytosolic (SOD1), a mitochondrial (SOD2),
and an extracellular (SOD3), which bind to both cell surfaces and extracellular matri-
ces [7]. sod3 gene is highly expressed in the lung, where it plays a major protective role
by controlling oxidative stress and inflammation and regulating redox homeostasis of2014 Constantino et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly credited.
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extracellular matrix by a heparan sulfate domain, which can be fragmented by oxidative
damage [5,9]. Furthermore, extracellular matrix fragments stimulate inflammatory cell
migration, which is of concern since matrix components are widely distributed
throughout the interstitium [9]. Proteolytic cleavage of SOD3's anchorage domain alters
its tissue distribution and, consequently, the oxidant/antioxidant balance [10].
In addition, bioactivity of nitric oxide (NO) partially depends on its interaction with ROS,
particularly superoxide anions [11]. NO reacts with superoxide to form peroxynitrite
(ONOO−), which induces protein oxidation and DNA damage [12]. SOD3 prevents the in-
activation of NO by superoxide; therefore, an increase in sod3 expression in blood vessels
preserves endothelial function by overcoming oxidative stresses [13]. Furthermore, several
evidences suggest that SOD3 may have a protective role against inflammation [10,14].
Thus, it was hypothesized that endogenous SOD3 could have a major role in lung de-
fenses against oxidative stress during sepsis development. The aims of this study are (1)
to determine if there is a relationship between the expression and activity of SOD and
the occurrence of oxidative stress and (2) to determine if the administration of a SOD
mimetic is able to prevent lung damage in an animal model of sepsis.
Methods
Animals
Three-month-old male Wistar rats (350 to 400 g) were obtained from our breeding col-
ony. The rats were caged in groups of five, had free access to food and water, and were
maintained on a 12-h light–dark cycle (600 to 1800 hours) in a temperature-controlled
colony room (22°C ± 1°C). The research protocol was approved by the Ethical Committee
for Animal Experimentation of Universidade do Extremo Sul Catarinense under protocol
number 21/2011.
Cecal ligation and perforation surgery
The animals were subjected to cecal ligation and perforation (CLP) as previously described
[15]. Briefly, the rats were anesthetized with ketamine (80 mg/kg). Under aseptic conditions,
a 3-cm midline laparotomy was performed to allow exposure of the cecum with the adjoin-
ing intestine. The cecum was tightly ligated with a 3.0 silk suture at its base (below the ileo-
cecal valve) and was then perforated a single time with a 14-gauge needle. The cecum was
gently squeezed to extrude a small amount of feces from the perforation site into the peri-
toneal cavity. The animals were resuscitated with normal saline (50 mL/kg, subcutaneous)
immediately and 12 h after CLP. The sham-operated group was submitted to all surgical
procedures, but the cecum was neither ligated nor perforated. The animals were killed by
decapitation at 3, 6, and 12 h after surgery, and the lung was removed for subsequent ana-
lyses. The number of animals in each group per experiment was ten. In some experiments,
a SOD mimetic was administered once by intra-tracheal instillation immediately after CLP
induction (50 mg/kg), and the lung was removed 24 h after for subsequent analyses. This
mimetic has been previously described by Horn et al. [16].Total SOD activity
The SOD activity was measured by inhibition of adrenaline auto-oxidation followed by
spectrophotometry as previously described [17].
Constantino et al. Intensive Care Medicine Experimental 2014, 2:17 Page 3 of 11
http://www.icm-experimental.com/content/2/1/17Immunoblotting
The lung samples were lysed in Laemmli sample buffer (62.5 mM Tris–HCl, pH 6.8,
1% (w/v) SDS, 10% v/v) glycerol). Protein (30 μg) was fractionated by SDS-
polyacrylamide gel electrophoresis and then electroblotted onto nitrocellulose mem-
branes. Protein loading and electroblotting efficiencies were verified by Ponceau S
staining. The membrane was blocked in Tween-Tris-buffered saline (TTBS, 100 mM
Tris–HCl, pH 7.5, containing 0.9% NaCl and 0.1% Tween-20) containing 5% albumin.
The membranes were incubated overnight at 4°C with rabbit polyclonal antibody, tar-
geting SOD1 (Santa Cruz Biotechnology, CA, USA) (dilution range 1:400), SOD2 (Santa
Cruz Biotechnology) (dilution range 1:400), SOD3 (Santa Cruz Biotechnology) (dilution
range 1:750), iNOS (Santa Cruz Biotechnology) (dilution range 1:400) or anti-β-actin
1:2000, in the presence of 5% milk. Thereafter, the membranes were washed with TTBS.
Anti-rabbit immunoglobulin G (IgG) peroxidase-linked secondary antibody was incubated
(1:10,000 dilution range), and the immunoreactivity was detected by enhanced chemilu-
minescence using ECL Plus kit (Thermo Fisher Scientific Inc., Pittsburgh, PA, USA).
Densitometric analyses of the films were performed with ImageQuant software (GE
Healthcare Life Sciences, Billerica, MA, USA). The blots were developed such that the sig-
nals are linear and non-saturating which are required for densitometry. All results were
expressed as a relative ratio comparing the immunocontent of SOD1, SOD2, SOD3, and
iNOS with that of the β-actin internal control [18].Enzyme-linked immunosorbent assay to 3-nitrotyrosine contents
An indirect enzyme-linked immunosorbent assay (ELISA) was performed to analyze the
changes in 3-nitrotyrosine content. Briefly, an anti-3-nitrotyrosine polyclonal rabbit anti-
body (Santa Cruz Biotechnology) was diluted 2,000-fold in PBS with 5% albumin according
to the manufacturer's instructions. Then, microtiter plates (96 wells, with flat bottom) were
coated for 24 h with the samples that had been diluted 1:2 in PBS with 5% albumin. The
plates were washed four times with wash buffer (PBS with 0.05% Tween-20), and the anti-
body was added to each plate for 2 h at room temperature. After washing, a second incuba-
tion with anti-rabbit antibody peroxidase conjugate (diluted 1:1,000) was performed for 1 h
at room temperature. After the addition of substrates, the samples were read in a plate spec-
trophotometer at 450 nm. The results are expressed as changes in the percentage among
the groups [19].Semi-quantitative reverse transcription polymerase chain reaction
All transcriptional analyses were performed in the samples in which prior Western
blotting experiments revealed differences in the immunocontent. The goal was to
evaluate the contribution of each gene to transcriptional changes in the immunocon-
tent of each enzyme. Total RNA was isolated from the rat lung using TRIzol® reagent
(Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. Using a
spectrophotometer, the purity of the RNA was quantified by calculating the ratio be-
tween absorbance values at 260 and 280 nm, and its integrity was confirmed by electro-
phoresis using a 1.0% agarose gel. Afterward, cDNA species were synthesized using
ImProm-II™ Reverse Transcription System (Promega®, Madison, WI, USA), as described
by the supplier's instruction. The cDNA products (1 μL) were used as a template for
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optimized. Thereafter, the reactions were performed, such that product detection could
be performed within the linear phase of messenger ribonucleic acid (mRNA) transcript
amplification for each primer pair (Table 1). PCR for the β-actin gene was performed
in a total volume of 20 μL using 0.1 μM of each primer, 0.2 μM dNTP, 1.6 mM MgCl2,
and 0.2 U Taq platinum DNA polymerase (Invitrogen). For PCR amplification of sod1,
sod2, and sod3, the reaction was performed in a total volume of 25 μL using 0.2 μM of
each primer, 0.2 μM dNTP, 1.6 mM MgCl2, and 0.25 U Taq platinum DNA polymerase
(Invitrogen). The conditions for sod1, sod2, and sod3 PCRs were as follows: initial
1-min denaturation step at 94°C, another 1-min denaturation step at 94°C, 1-min an-
nealing step at 60°C, 1-min extension step at 72°C for 30 cycles, and a final 10-min ex-
tension at 72°C. The conditions for the β-actin PCR were as follows: initial 1-min
denaturation step at 94°C, another 1-min denaturation step at 94°C, 1-min annealing
step at 54°C, 1-min extension step at 72°C for 35 cycles, and a final 10-min extension
at 72°C. For each PCR set, a negative control was included. The PCR products were
then analyzed on a 1% agarose gel containing GelRed® (Biotium, Hayward, CA, USA)
and visualized with ultraviolet light. The Low DNA Mass Ladder (Invitrogen) was used
as a molecular marker, and the samples were normalized against the constitutively
expressed β-actin gene. The band intensities were measured by optical densitometry
analysis, and the enzyme/β-actin mRNA ratios were established for each treatment
using the freeware Image J 1.37. Each experiment was repeated at least four times using
RNA isolated from independent extractions.
Immunohistochemistry
Lung sections (sham 0 and 12 and CLP 0 and 12, n = 3 in each group) were deparaffi-
nized and hydrated. To examine their histological features, the lungs were stained with
hematoxylin and eosin (H&E). After blocking of endogenous peroxidase, antigen re-
trieval was performed in a high-temperature Tris-citrate buffer (pH 7.2). The rabbit
polyclonal anti-SOD3 (Santa Cruz Biotechnology) (diluted 1:1,600) was used as the pri-
mary antibody. The Vectastin ABC Kit (Vector Laboratories, Burlingame, CA, USA)
was used as the secondary antibody, and 3,3-diaminobenzidine (DAB, Sigma, St. Louis,
MO, USA) was used as the chromogen. Thereafter, the sections were counterstained
with Harris hematoxylin (Merck, Darmstadt, Germany). In the negative controls, the
first antibody was omitted from the procedure, and the tissues were incubated with bo-
vine serum albumin (BSA) instead.Table 1 PCR primer design






sod1 F-TGCGTGCTGAAGGGCGACGGTC 60 438 BC082800
R-AATCCCAATCACACCACAAGCCAAGC
sod2 F-CCTACGTGAACAATCTGAACGTCACCGAG 60 373 BC070913.1
R-CCCAGCAGTGGAATAAGGCCTGTGG
sod3 F-GCCGAGCAGAACACCTCCAACCACG 60 377 BC061861.1
R-CGCCGCTTCTTGCGCTCCTTTG
β-actin F-TATGCCAACACAGTGCTGCTGG 54 210 NP_742006
R-TACTCCTGCTTCCTGATCCACAT
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Lung levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-10 were
determined by ELISA according to the manufacturer's instructions (PrepoTech,
Ribeirão Preto, SP, Brazil). All samples were assayed in duplicate.
Lung permeability assay
Permeability changes were measured by Evan's blue dye (EBD) leakage from the blood
into the airways. EBD (20 mg/kg) was administered by femoral vein injection 1 h before
the end of the experiments. One hour later, the mice were bled by cardiac puncture,
and the pulmonary vasculature was flushed by right ventricle puncture. The pulmonary
vessels were perfused with normal saline to remove EBD from the vascular spaces. The
lungs were removed en bloc and dried at 60°C for 24 h. EBD was extracted in formam-
ide at 37°C for 24 h and quantitated by its fluorescence intensity. The extravasated
EBD concentration in lung homogenate was calculated against a standard curve.
Statistical analysis
Data are expressed as mean ± standard deviation. The means for the different groups were
compared by t test or one-way or two-way ANOVA followed by Tukey test, depending on
the number of experimental groups. Statistical significance was assigned to p < 0.05.Results
Levels of SOD were determined in the lung 3 to 12 h after sepsis. There was a decrease
in the immunocontent of SOD1 at 3 and 12 hours, but not at 6 h, after sepsis induction
(Figure 1A,B,C). Furthermore, an increase in the immunocontent of SOD2 was ob-
served at all times (Figure 2A,B,C), and there was an increase in the immunocontent of
SOD3 at 6 and 12 h after sepsis induction (Figure 3A,B,C). The SOD activity increasedFigure 1 Cytosolic superoxide dismutase (SOD1) alterations early after sepsis induction. The animals
were submitted to sepsis or sham-operated, and 3 h (A), 6 h (B), and 12 h (C) after surgery, the immunocontent
of SOD1 was evaluated. The sod1 gene expression was evaluated at 3 h (D) and 12 h (E) after surgery. The data
are expressed as mean ± SD (n = ten animals/group). p value < 0.05 was considered significant when compared
to the control. * denotes p < 0.05.
Figure 2 Mitochondrial superoxide dismutase (SOD2) alterations early after sepsis induction. The
animals were submitted to sepsis or sham-operated, and 3 h (A), 6 h (B), and 12 h (C) after surgery, the
immunocontent of SOD2 was evaluated. The sod2 gene expression was evaluated at 3 h (D), 6 h (E), and
12 h (F) after surgery. The data are expressed as mean ± SD (n = ten animals/group). p value < 0.05 was
considered significant when compared to the control.
Figure 3 Extracellular superoxide dismutase (SOD3) alterations early after sepsis induction. The
animals were submitted to sepsis or sham-operated, and 3 h (A), 6 h (B), and 12 h (C) after surgery, the
immunocontent of SOD3 was evaluated. The sod3 gene expression was evaluated at 3 h (D) and 12 h
(E) after surgery. The data are expressed as mean ± SD (n = ten animals/group). p value < 0.05 was considered
significant when compared to the control.
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Figure 4 Nitrotyrosine content early after sepsis induction. The animals were submitted to sepsis or
sham-operated, and 3, 6, and 12 h after surgery, the content of nitrotyrosine was evaluated. The data are
expressed as mean ± SD (n = ten animals/group). p value < 0.05 was considered significant when compared
to the control.
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protein, p = 0.01) when compared to the sham and CLP animals, respectively. To deter-
mine if these changes of protein content were associated with alterations in gene ex-
pression, semi-quantitative reverse transcription polymerase chain reaction (RT-PCR)
was performed. There was no consistent pattern of gene expression; while sod1 and
sod2 gene expressions increased 12 h after sepsis (Figure 1D,E and Figure 2D,E,F), sod3
gene expression decreased at this time point (Figure 3B).
Nitrotyrosine levels increased 3 and 12 hours after CLP induction (Figure 4), suggest-
ing that despite the increase of SOD3 content the reaction between superoxide and NO
was occurring. Lung content of iNOS did not increase in the lung of septic animals
(Figure 5A-C), but it was increased in the pulmonary artery (Figure 5D-E).
These alterations were associated with capillary congestion and infiltration of neutro-
phils into the alveolar septa (Figure 6). It was possible that the increase in SOD3 pro-
tein content did not protect the lung from oxidant injury due to a disorganized
distribution resulting from proteolytic cleavage of its heparin-binding domain, but SODFigure 5 Inducible nitric oxide synthase (iNOS) alterations early after sepsis induction. The animals
were submitted to sepsis or sham-operated, and 3 h (A), 6 h (B), and 12 h (C) after surgery, the immunocontent
of iNOS was evaluated in the lung and in the pulmonary artery (3 h (D), 6 h (E), 12 h (F)). The data are expressed
as mean ± SD (n= ten animals/group). p value < 0.05 was considered significant when compared to the control.
Figure 6 Distribution of extracellular superoxide dismutase (SOD3) in the lung early after sepsis.
The animals were submitted to sepsis or sham-operated, and 12 h after surgery, the distribution of lung
SOD3 was determined by immunohistochemistry. Representative photographs of septic (A) and sham
(B) animals. Original magnification is × 6,200.
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bronchial and alveolar epithelia of the CLP animals and to a minor extent in the leuko-
cytes and endothelial cells (Figure 6).
It was expected that SOD3 protected the lung from oxidative damage and inflamma-
tion, but this was not supported by the presented data. Thus, it was administered a
SOD mimetic, and it decreased the lung nitrotyrosine and cytokine levels, as well as
preserved lung permeability (Figure 7A,B,C).
Discussion
Here, in a CLP model, we demonstrated that during sepsis development, the levels of
SOD2 and SOD3 increased in the lung, but these did not prevent nitrosative damage
and inflammation. Furthermore, we showed that superoxide-derived lung inflammation
could be attenuated by the administration of an exogenous SOD mimetic.
An increase in the levels of SOD2 and SOD3 was observed; thus, it was believed that
the lung was protected from superoxide-derived oxidative damage. SOD3 is a potent
inhibitor of inflammation in lung injury models [20], and mice lacking the sod3 gene
are more sensitive to lethal levels of hyperoxia [14]. Furthermore, SOD3 protects
against endothelial dysfunction in mice treated with endotoxin [21]. In a murine model
of emphysema, the mice that overexpress the sod3 gene or are treated with a SOD mi-
metic have improved lung compliance, decreased neutrophil influx, release of proin-
flammatory mediators, and oxidative damage [22]. Here, we show that despite the
increase in SOD content, there is an increase in lung nitrotyrosine content.
In general, inflammatory conditions (including lipopolysaccharide, hypoxia, asbestos
exposure, bleomycin, and hyperoxia) induce a decrease in SOD3 content. This observa-
tion is most likely a result of proteolysis of its heparin-binding domain rather than al-
terations in its gene expression [20,23]. In contrast, at earlier time points after sepsis
induction, we demonstrate an increase in SOD3 levels that are properly distributed
throughout the lung parenchyma, but this is not sufficient to prevent the formation of
peroxynitrite. Increased oxidative damage, despite the presence of higher levels of
SOD3, was described in a model of cerebral ischemia [24].
The reaction of NO with superoxide may lead to an increase in ONOO−, which me-
diates nitration of tyrosine residues in certain enzymes, including SODs. This modifica-
tion leads to a reduction in their activity and, as a result, further increase in superoxide
Figure 7 Effects of the treatment with a SOD mimetic on lung injury induced by sepsis. The animals
were submitted to sepsis or sham-operated, and immediately after surgery, a SOD mimetic was administered
once by intra-tracheal instillation. Twenty-four hours after surgery, the content of nitrotyrosine (A), lung permeability
(B), interleukin-6 (C), and tumor necrosis factor (D) was determined. The data are expressed as mean ± SD (n= ten
animals/group). p value < 0.05 was considered significant when compared to the control.
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to the structural similarity between SOD1 and SOD3, we speculate that the activity of
SOD3 may similarly be decreased by ONOO−. Here, we demonstrate that septic ani-
mals have increased levels of nitrotyrosine. This occurs even in the presence of higher
SOD3 levels and total SOD activity. This pattern is not expected since in different
models, an increase in SOD3 activity is usually associated with a decrease in ONOO−
[28]. However, when we used an exogenous SOD mimetic, it is observed that there is a
decrease in the nitrotyrosine levels. These observations suggest that the endogenous
SOD system is not able to prevent oxidative damage in the CLP model. In addition, a
SOD mimetic decreased the markers of lung inflammation and improved lung perme-
ability. Moreover, these findings raise the possibility that SOD mimetics could be used
to treat sepsis-related lung injury.
There are some limitations to our study. Firstly, SOD mimetic was administered im-
mediately after CLP, when the septic response was not fully developed and animals did
not presented clinical signs of severe infection. Thus, this design did not reflect the
clinical scenario, but can be relevant to understand the mechanisms associated with
sepsis development. Secondly, nitrotyrosine was not measured by gold-standard
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raphy. Since the increase of nitrotyrosine is classically found in sepsis models, the use
of semi-quantitative ELISA as a marker of oxidative damage seems to be adequate to
the study aim.
Conclusions
In conclusion, this study demonstrated an increase in SOD3 levels following sepsis;
however, this was not able to prevent oxidative stress and inflammation associated with
ONOO− production. Nonetheless, the administration of a SOD mimetic had a positive
impact, which suggests that administration of exogenous SOD may improve lung func-
tion in sepsis.
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